# Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Sep 26, 2020

- Company: [Thermo Fisher Scientific Inc.](/companies/tmo.md) (CIK 97745)
- Form: 10-Q
- Filed: 2020-10-30
- Accepted by EDGAR: Oct 30, 2020, 10:34 ET
- Period: 2020-09-26
- Accession: 0000097745-20-000051
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/97745/000009774520000051/tmo-20200926.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/97745/000009774520000051/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-26.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-06-28 to 2020-09-26 | $8.52bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2020-01-01 to 2020-09-26 | $21.67bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months, 2020-06-28 to 2020-09-26 | $296.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2020-01-01 to 2020-09-26 | $805.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-06-28 to 2020-09-26 | $1.59bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2020-01-01 to 2020-09-26 | $4.85bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-06-28 to 2020-09-26 | $2.43bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2020-01-01 to 2020-09-26 | $4.72bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-06-28 to 2020-09-26 | $144.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2020-01-01 to 2020-09-26 | $407.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-06-28 to 2020-09-26 | $319.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2020-01-01 to 2020-09-26 | $456.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-06-28 to 2020-09-26 | $1.93bn | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months, 2020-01-01 to 2020-09-26 | $3.88bn | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2020-06-28 to 2020-09-26 | $4.84 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2020-01-01 to 2020-09-26 | $9.71 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-06-28 to 2020-09-26 | $4.88 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2020-01-01 to 2020-09-26 | $9.79 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-06-28 to 2020-09-26 | 399,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2020-01-01 to 2020-09-26 | 399,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2020-01-01 to 2020-09-26 | $4.95bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2020-01-01 to 2020-09-26 | $888.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2020-01-01 to 2020-09-26 | $250.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2020-01-01 to 2020-09-26 | $1.50bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-09-26 | $7.54bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-09-26 | $18.23bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-26 | $64.06bn | us-gaap:Assets |
| Current liabilities | at 2020-09-26 | $6.23bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2020-09-26 | $21.09bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-09-26 | $2.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2020-09-26 | $31.82bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2020-09-26 | 396,335,191 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/97745/000009774520000051/tmo-20200926.htm

Filed Oct 30, 2020.
Source: SEC EDGAR, the filing index for accession 0000097745-20-000051. Last ingested by Listed: Nov 14, 2026, 12:05 ET. No prices; not investment advice.
